Rajan Sharma
Stock Analyst at Goldman Sachs
(0)
# 4851
Out of 5,370 analysts
7
Total ratings
0.00%
Success rate
-20.58%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DBVT DBV Technologies | Reinstates: Sell | 8 | 9.44 | -23.2% | 1 | May 29, 2025 | |
AZN AstraZeneca | Initiates Coverage On: Buy | 97 | 73.48 | 32.01% | 1 | May 30, 2024 | |
GSK GSK | Initiates Coverage On: Neutral | 47 | 40.48 | 16.11% | 1 | May 30, 2024 | |
MOR MorphoSys | Maintains: Neutral | 10 5 | n/a | n/a | 2 | Nov 22, 2023 | |
IMCR Immunocore Hldgs | Reiterates: Overweight | 79 | 32.63 | 142.11% | 2 | Jun 20, 2023 |